CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value: $82.43M (100.0% shares, 0.0% debt)

Holdings (25)

— STRONGBRIDGE BIOPHARMA PLC 35.9%

Value $29.59M Shares 6,604,065 Share Price $4.48 Est. Cost/Share $2.92 Unrealized @ Report Date —

— MEI PHARMA INC 11.1%

Value $9.132M Shares 3,459,124 Share Price $2.64 Est. Cost/Share $3.94 Unrealized @ Report Date —

— GARRISON CAP INC 9.5%

Value $7.83M Shares 1,217,722 Share Price $6.43 Est. Cost/Share $8.25 Unrealized @ Report Date —

— KALA PHARMACEUTICALS INC 8.1%

Value $6.639M Shares 1,357,639 Share Price $4.89 Est. Cost/Share $5.08 Unrealized @ Report Date —

— MOLECULAR TEMPLATES INC 8.0%

Value $6.562M Shares 1,624,241 Share Price $4.04 Est. Cost/Share $6.39 Unrealized @ Report Date —

— CM FIN INC 7.8%

Value $6.427M Shares 1,028,355 Share Price $6.25 Est. Cost/Share $8.08 Unrealized @ Report Date —

— ALPS ETF TR 4.4%

Value $3.596M Shares 411,873 Share Price $8.73 Est. Cost/Share $10.10 Unrealized @ Report Date —

SPY SPDR S&P 500 ETF TR 4.2%

Value $3.501M Shares 14,010 Share Price $249.89 Est. Cost/Share $249.89 Unrealized @ Report Date —

— SCYNEXIS INC 2.5%

Value $2.083M Shares 4,325,000 Share Price $0.48 Est. Cost/Share $1.30 Unrealized @ Report Date —

BRK/B BERKSHIRE HATHAWAY INC DEL 2.3%

Value $1.901M Shares 9,312 Share Price $204.15 * Est. Cost/Share $135.71 Unrealized @ Report Date +53.9%

JBGS JBG SMITH PPTYS 0.9%

Value $778K Shares 22,349 Share Price $34.81 Est. Cost/Share $34.27 Unrealized @ Report Date —

— ALCENTRA CAP CORP 0.6%

Value $487K Shares 75,303 Share Price $6.47 Est. Cost/Share $7.79 Unrealized @ Report Date —

KURA KURA ONCOLOGY INC 0.6%

Value $461K Shares 32,828 Share Price $14.04 * Est. Cost/Share $18.11 Unrealized @ Report Date -26.9%

ACRS ACLARIS THERAPEUTICS INC 0.5%

Value $453K Shares 61,264 Share Price $7.39 * Est. Cost/Share $17.06 Unrealized @ Report Date -39.6%

— EIGER BIOPHARMACEUTICALS INC 0.5%

Value $444K Shares 43,709 Share Price $10.16 Est. Cost/Share $11.23 Unrealized @ Report Date —

— FS KKR CAPITAL CORP 0.5%

Value $421K Shares 81,348 Share Price $5.18 Est. Cost/Share $5.18 Unrealized @ Report Date —

— ARQULE INC 0.4%

Value $345K Shares 124,435 Share Price $2.77 Est. Cost/Share $4.86 Unrealized @ Report Date —

— INTEC PHARMA LTD JERUSALEM 0.4%

Value $318K Shares 42,236 Share Price $7.53 Est. Cost/Share $8.94 Unrealized @ Report Date —

— MARKER THERAPEUTICS INC 0.4%

Value $296K Shares 53,329 Share Price $5.55 Est. Cost/Share $5.55 Unrealized @ Report Date —

ARCC ARES CAP CORP 0.3%

Value $273K Shares 17,553 Share Price $15.55 * Est. Cost/Share $8.36 Unrealized @ Report Date 0.0%

— FAR PT ACQUISITION CORP 0.3%

Value $262K Shares 27,116 Share Price $9.66 Est. Cost/Share $9.66 Unrealized @ Report Date —

— SPRING BK PHARMACEUTICALS IN 0.3%

Value $219K Shares 21,034 Share Price $10.41 Est. Cost/Share $12.06 Unrealized @ Report Date —

— MARINUS PHARMACEUTICALS INC 0.2%

Value $176K Shares 61,443 Share Price $2.86 Est. Cost/Share $4.24 Unrealized @ Report Date —

— DICERNA PHARMACEUTICALS INC 0.2%

Value $149K Shares 13,948 Share Price $10.68 Est. Cost/Share $15.28 Unrealized @ Report Date —

— CTI BIOPHARMA CORP 0.1%

Value $91,000 Shares 123,941 Share Price $0.73 Est. Cost/Share $2.16 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	STRONGBRIDGE BIOPHARMA PLC	6,604,065	$29.59M	35.9%	$4.48	$2.92	—	SHS USD	G85347105
—	MEI PHARMA INC	3,459,124	$9.132M	11.1%	$2.64	$3.94	—	COM NEW	55279B202
—	GARRISON CAP INC	1,217,722	$7.83M	9.5%	$6.43	$8.25	—	COM	366554103
—	KALA PHARMACEUTICALS INC	1,357,639	$6.639M	8.1%	$4.89	$5.08	—	COM	483119103
—	MOLECULAR TEMPLATES INC	1,624,241	$6.562M	8.0%	$4.04	$6.39	—	COM	608550109
—	CM FIN INC	1,028,355	$6.427M	7.8%	$6.25	$8.08	—	COM	12574Q103
—	ALPS ETF TR	411,873	$3.596M	4.4%	$8.73	$10.10	—	ALERIAN MLP	00162Q866
SPY	SPDR S&P 500 ETF TR	14,010	$3.501M	4.2%	$249.89	$249.89	—	TR UNIT	78462F103
—	SCYNEXIS INC	4,325,000	$2.083M	2.5%	$0.48	$1.30	—	COM	811292101
BRK/B	BERKSHIRE HATHAWAY INC DEL	9,312	$1.901M	2.3%	$204.15 *	$135.71	+53.9%	CL B NEW	084670702
JBGS	JBG SMITH PPTYS	22,349	$778K	0.9%	$34.81	$34.27	—	COM	46590V100
—	ALCENTRA CAP CORP	75,303	$487K	0.6%	$6.47	$7.79	—	COM	01374T102
KURA	KURA ONCOLOGY INC	32,828	$461K	0.6%	$14.04 *	$18.11	-26.9%	COM	50127T109
ACRS	ACLARIS THERAPEUTICS INC	61,264	$453K	0.5%	$7.39 *	$17.06	-39.6%	COM	00461U105
—	EIGER BIOPHARMACEUTICALS INC	43,709	$444K	0.5%	$10.16	$11.23	—	COM	28249U105
—	FS KKR CAPITAL CORP	81,348	$421K	0.5%	$5.18	$5.18	—	COM	302635107
—	ARQULE INC	124,435	$345K	0.4%	$2.77	$4.86	—	COM	04269E107
—	INTEC PHARMA LTD JERUSALEM	42,236	$318K	0.4%	$7.53	$8.94	—	SHS	M53644106
—	MARKER THERAPEUTICS INC	53,329	$296K	0.4%	$5.55	$5.55	—	COM	57055L107
ARCC	ARES CAP CORP	17,553	$273K	0.3%	$15.55 *	$8.36	0.0%	COM	04010L103
—	FAR PT ACQUISITION CORP	27,116	$262K	0.3%	$9.66	$9.66	—	COM CL A	30734W109
—	SPRING BK PHARMACEUTICALS IN	21,034	$219K	0.3%	$10.41	$12.06	—	COM	849431101
—	MARINUS PHARMACEUTICALS INC	61,443	$176K	0.2%	$2.86	$4.24	—	COM	56854Q101
—	DICERNA PHARMACEUTICALS INC	13,948	$149K	0.2%	$10.68	$15.28	—	COM	253031108
—	CTI BIOPHARMA CORP	123,941	$91,000	0.1%	$0.73	$2.16	—	COM NEW	12648L601